The neuroendocrinology of childhood obesity

Pediatric Clinics of North America

Volumn 48, Issue 4, 2001, Pages 909-930

  Lustig, Robert H ^b  

^a LE BONHEUR CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR MODIFICATION; CALORIC INTAKE; CHILD; CHILDHOOD DISEASE; DIET; ENERGY BALANCE; ENERGY EXPENDITURE; EXERCISE; HUMAN; HUNGER; HYPOTHALAMUS; METABOLIC REGULATION; NEGATIVE FEEDBACK; NEUROENDOCRINOLOGY; OBESITY; REVIEW; SATIETY; WEIGHT GAIN;

EID: 0034906868     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(05)70348-5     Document Type: Article

References (124)

1. Obesity and diabetic control
2. Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement
3. The heritability of body mass index among an international sample of monozygotic twins reared apart
4. In vivo effects of hyperinsulinemia on lipogenic enzymes and glucose transporter expression in rat liver and adipose tissues
5. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine, and placebo in obese subjects on an energy-restricted diet: A double-blind trial
6. Effects of nutrient intake on sympatho-adrenal activity and thermogenic mechanisms
7. Leptin enters the brain by a saturable system independent of insulin
8. Genetics of body-weight regulation
9. Insulin and insulin-like growth factors in the CNS
10. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo: A mechanism for regulated insulin delivery to the brain
11. Chronic and continuous intracerebroventricular infusion of neuropeptide Y in Long-Evans rats mimics the feeding behavior of obese Zucker rats
12. Energy metabolism during the post exercise recovery period
13. Acute hyperinsulinemia and its reversal by vagotomy following lesions of the ventromedial hypothalamus in anesthetized rats
14. Identification of SOCS-3 as a potential mediator of central leptin resistance
15. 4-adrenergic receptor on the expression of uncoupling proteins and peroxisome proliferator-activated receptor-γ coactivator-1
16. Syndromes of hypothalamic obesity in man
17. Sibutramine produces dose-related weight loss
18. Manifestations of hypothalamic obesity in man: A comprehensive investigation of eight patients and a review of the literature
19. Current and potential drugs for treatment of obesity
20. Hypothalamic obesity
21. The neuropeptide Y/agouti gene related protein (AgRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice
22. Role of brain insulin receptor in control of body weight and reproduction
23. Role of the melanocortin system in the neuroendocrine control of energy homeostasis
24. Leptin increases serotonin turnover by inhibition of nitric oxide synthesis
25. Decreased cerebrospinal fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance
26. Correlations between autonomic function, β-cell activity, insulin sensitivity, and glucose tolerance in obesity
27. An endocrine and metabolic definition of the intermeal interval in humans: Evidence for a role of leptin on the prandial pattern through fatty acid disposal
28. Early onset of reproductive function in normal female mice treated with leptin
29. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
30. 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity
31. The central melanocortin system and energy homeostasis
32. Hyperinsulinemia increases the amount of GLUT4 mRNA in white adipose tissue and decreases that of muscles: A clue for increased fat depot and insulin resistance
33. Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins
34. Energy expenditure
35. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine
36. Central leptin modulates behavioral and neural responsivity to CCK
37. Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei
38. From lesions to leptin: Hypothalamic control of food intake and body weight
39. Effects of recombinant leptin therapy in a child with congenital leptin deficiency
40. Phenotypic description of a novel human obesity syndrome associated with mutations in the melanocortin 4 receptor
41. Leptin and the regulation of body weight in mammals
42. Progress report on the anorectic effects of dexfenfluramine, fluoxetine, and sertraline
43. Glucagon acts in the liver to control spontaneous meal size in rats
44. Vagotomy abolishes cues of satiety produced by gastric distention
45. Overexpression of Agrt leads to obesity in transgenic mice
46. Clinical studies with dexfenfluramine: From past to future
47. Serum leptin in children with obesity: Relationship to gender and development
48. Receptor-mediated regional sympathetic nerve activation by leptin
49. Recombinant leptin for weight loss in obese and lean adults: A randomized, controlled, dose-escalation trial
50. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans
51. Functional characterization of mutations in melanocortin-4 receptor associated with human obesity
52. A receptor in pituitary and hypothalamus that functions in growth hormone release
53. 2+ channels in the beta-cell
54. The effect of subdiaphragmatic vagotomy in rats with ventromedial hypothalamic lesions
55. Obesity and impaired prohormone processing associated with mutations in the prohormone convertase 1 gene
56. Effect of sibutramine on weight maintenance after weight loss: A randomized trial
57. A population-based study of appetite-suppressant drugs and the risk of cardiac valve regurgitation
58. Fuel metabolism, energy expenditure, and thyroid function in growth hormone-treated obese women: A double-blind, placebo-controlled study
59. Nutritional infertility: The role of the interconnected hypothalamic neuropeptide Y-galanin-opioid network
60. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression
61. Cytokine signal transduction
62. Ghrelin is a growth-hormone-releasing acylated peptide from stomach
63. Hypothalamic CART is a new anorectic peptide regulated by leptin
64. Severe early-onset obesity, adrenal insufficiency, and red hair pigmentation caused by POMC mutations in humans
65. Abnormal splicing of the leptin receptor in diabetic mice
66. Changes in energy expenditure resulting from altered body weight
67. Chronic norepinephrine injection into the hypothalamic paraventricular nucleus produces hyperphagia and increased body weight in the rat
68. Role of nonexercise activity thermogenesis in resistance to fat gain in humans
69. Brain peptides and obesity: Pharmacologic treatment
70. Effects of serotonin and the serotonin blocker metergoline on meal patterns and macronutrient selection
71. Towards a molecular understanding of adaptive thermogenesis
72. A double-blind, placebo-controlled trial of octreotide in pediatric hypothalamic obesity
73. Risk factors for obesity in children surviving brain tumors
74. Hypothalamic obesity in children caused by cranial insult: Altered glucose and insulin dynamics, and reversal by a somatostatin agonist
75. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys: Rising leptin levels may signal the onset of puberty
76. Role of intrahypothalamic insulin in circadian patterns of food intake, activity, and body temperature
77. Colocalization of somatostatin receptor sst5 and insulin in rat pancreatic β-cells
78. 2+ pools
79. Congenital leptin deficiency is associated with severe early-onset obesity in humans
80. Identification of receptor populations mediating the satiating actions of brain and gut peptides
81. Phenylpropanolamine and blood pressure: A review of prospective studies
82. 2c receptor gene
83. Hormonal factors influencing weight and growth pattern in craniopharyngioma
84. Neural pathways involved in the hypothalamic integration of autonomic responses
85. Body fat in identical twins reared apart: Role for genes and environment
86. Hyperphagia, rage, and dementia accompanying a ventromedial hypothalamic neoplasm
87. Consequences of ventromedial hypothalamic lesions upon insulin and glucagon secretion by subsequently isolated perfused pancreases in the rat
88. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo
89. Sibutramine: A novel new agent for obesity treatment
90. Pathophysiological significance of the obese gene product, leptin in ventromedial hypothalamus (VMH)-lesioned rats: Evidence for loss of its satiety effect in VMH-lesioned rats
91. Insulin and the central regulation of energy balance: Update 1994
92. Central nervous system control of food intake
93. Independent effects of obesity and insulin resistance on postprandial thermogenesis in man
94. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice
95. Acute post-challenge hyperinsulinemia predicts weight gain
96. Serotonergic control of the organization of feeding and satiety
97. Thermogenic response to epinephrine in the forearm and abdominal subcutaneous tissue
98. Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene
99. The ciliary neurotrophic factor and its receptor, CNTFR alpha
100. Children with craniopharyngioma: Early growth failure and rapid post-operative weight gain
101. Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels
102. Long-term follow-up of children with craniopharyngioma
103. The role of neuropeptide Y in the antiobesity action of the obese gene product
104. 3-adrenergic receptor gene
105. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice
106. Effect of vagotomy on serum insulin in rats with paraventricular or ventromedial hypothalamic lesions
107. Overweight prevalence and trends for children and adolescents
108. Ghrelin induces adiposity in rodents
109. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity
110. Insulin and satiety from feeding in pancreatic-normal and diabetic rats
111. Insulin is a prandial satiety hormone
112. Suppression of insulin hypersecretion induces weight loss in a subject of obese adults
113. 3-adrenergic receptor gene
114. Phenylpropanolamine as an anorexiant agent in weight control: A review of published and unpublished studies
115. Long-term weight control (parts 1-7): The National Heart, Lung, and Blood Institute funded multimodal intervention study
116. Reversal of cirazoline-induced and phenylpropanolamine-induced anorexia by the alpha-1-receptor antagonist prazosin
117. Early adiposity rebound and the risk of adult obesity
118. 3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns
119. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat
120. Suppression of food intake in rats by fluoxetine: Comparison of enantiomers and effects of serotonin antagonists
121. Elevated post-prandial insulin levels do not induce satiety in normal-weight humans
122. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons
123. Positional cloning of the mouse obese gene and its human homologue